Cargando…
Development of novel apoferritin formulations for antitumour benzothiazoles
BACKGROUND: The benzothiazole structure is important in medicinal chemistry, and 5‐fluoro‐2‐(3,4‐dimethoxyphenyl) benzothiazole (GW 610) is of particular interest as it shows outstanding anticancer activity in sensitive breast and colorectal carcinoma cell lines via generation of lethal DNA adducts...
Autores principales: | Breen, Alastair F., Wells, Geoffrey, Turyanska, Lyudmila, Bradshaw, Tracey D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941424/ https://www.ncbi.nlm.nih.gov/pubmed/32721126 http://dx.doi.org/10.1002/cnr2.1155 |
Ejemplares similares
-
Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells
por: Quilles Junior, José C., et al.
Publicado: (2019) -
Apoferritin-Encapsulated Jerantinine A for Transferrin
Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy
por: Abuzaid, Haneen, et al.
Publicado: (2022) -
Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery
por: Breen, Alastair F, et al.
Publicado: (2019) -
In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles
por: Bradshaw, T D, et al.
Publicado: (2002) -
New Treatments in Renal Cancer: The AhR Ligands
por: Itkin, Boris, et al.
Publicado: (2020)